Semaglutide Weight Loss in San Antonio | From $175 | DaVida
Semaglutide Weight Loss in San Antonio | From $175 | DaVida
Couldn't load pickup availability
Medically-supervised semaglutide weight loss program.
Semaglutide is a GLP-1 receptor agonist medication FDA-approved for medical weight loss — the same compound found in well-known weight-loss medications. At DaVida Medical Aesthetics in San Antonio, our semaglutide program is medically supervised, with weekly self-administered injections, ongoing provider support, and tiered pricing that rewards clients committing to a longer program. New patients can start with our 6-week starter pack to confirm tolerance and initial response.
Why people reach for it
Every semaglutide program at DaVida is supervised by a licensed provider — meaning eligibility screening, dose calibration, side-effect management, and ongoing monitoring through your treatment course.
Clinical research shows semaglutide produces meaningful weight loss for most patients — typically 5–15% of body weight over a sustained treatment course, with continued benefit at higher doses and longer durations.
Once you're set up with your prescription and trained on injection technique, treatment is a quick weekly self-injection at home — minimal impact on schedule.
From a 6-week starter pack ($175) to a 1-year program ($2,400), our pricing structure rewards clients ready to commit to the duration that produces lasting results.
Who it's for
Semaglutide may be right for clients dealing with:
Why it works
Semaglutide mimics the body's natural GLP-1 hormone, which regulates appetite, slows gastric emptying, and signals satiety — meaning you feel fuller longer on less food.
Beyond weight loss, semaglutide improves how your body responds to insulin — making it FDA-approved for type 2 diabetes management alongside its weight-loss applications.
Food stays in your stomach longer, creating prolonged fullness after meals and reducing the snack-and-graze patterns that drive overeating.
Doses start low and titrate up gradually — your provider adjusts based on your response and side-effect profile, ensuring tolerable progress toward your weight loss goals.
What to expect
- Initial consultation: medical history, eligibility screening, goals discussion
- Bloodwork if needed; prescription provided
- Injection training and starter pack picked up
- Begin weekly self-administered injections
- Weeks 1–4: Initial low dose; tolerance and response assessed
- Weeks 4–12: Dose typically titrates up; weight loss begins
- Months 3–12: Sustained progress; provider check-ins
- Maintenance: continue at therapeutic dose or transition off based on goals
Common questions
How much does Semaglutide cost at DaVida?
We offer four pricing tiers based on commitment length: 6-week starter pack for new patients ($175), monthly ($350), 3-month ($852), and 1-year ($2,400). Longer commitments save meaningfully — the 1-year program saves over $1,800 compared to monthly pricing.
Is semaglutide the same as Ozempic or Wegovy?
Semaglutide is the active compound in both Ozempic and Wegovy. The branded medications are formulated and marketed for specific FDA-approved indications. Compounded semaglutide is the same active ingredient prepared by a licensed compounding pharmacy — making the treatment more accessible and affordable than the branded options.
What are the common side effects?
The most common side effects are gastrointestinal — nausea, mild stomach upset, and occasionally constipation or diarrhea, particularly in the first weeks of treatment. These typically resolve as your body adjusts to the medication. Your provider will monitor for these and adjust dosing if needed. Serious side effects are rare but discussed during eligibility screening.
How quickly will I see results?
Most patients see initial weight loss within the first 4–8 weeks. Significant weight loss (5–10% of body weight) is typically achieved by months 3–6. Maximum results often occur over 9–12 months of treatment. Individual responses vary based on starting weight, dose, and lifestyle factors.
Semaglutide vs Tirzepatide — which is right for me?
Both are GLP-1 medications with weight-loss applications. Tirzepatide (the active compound in Mounjaro/Zepbound) is a dual GLP-1 + GIP agonist and tends to produce somewhat greater weight loss in clinical trials. Semaglutide has a longer track record. Your provider helps decide based on your medical history, goals, and tolerance.
Who isn't a candidate for semaglutide?
Semaglutide isn't appropriate for clients with personal/family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastroparesis, or pregnancy/breastfeeding. Eligibility is screened during your initial consultation. We never start anyone who isn't a confirmed appropriate candidate.
"Semaglutide is one of the most-studied weight loss medications in modern medicine — and our medical supervision means every client is monitored, calibrated, and supported through their program. The pricing structure makes longer commitments meaningfully more accessible, and longer treatment is what produces lasting results. The science backs this; the support is what makes it sustainable."
- ✓Free shipping over $150
- ✓Authorized retailer
- ✓Aesthetician approved
- ✓San Antonio pickup available